Glaxo turns to Sidley for new GC
Share
GlaxoSmithKline (GSK) has hit the US for its new general counsel, hiring Sidley Austin life sciences partner Dan Troy after a seven month search.
Former GSK general counsel Rupert Bondy joined energy company BP in May after announcing his departure in January this year. Troy will start the top job at GSK on 2 September.
Troy has been at Sidley Austin for the past four years, serving as a partner in the life sciences practice as well as in the appellate litigation group. In addition to private practice he has experience of in-house legal work, having been chief counsel for the US Food and Drug Administration (FDA), where he served as a primary liaison to the White House and the US Department of Health and Human Services (HHS).
He served for three years at the FDA, between 2001 and 2004, before joining Sidley Austin.
Troy will report to Andrew Witty, GSK's chief executive officer. Witty said: "Dan's wealth of experience in the regulatory legislative area will be of enormous benefit to us, and ultimately to patients."
Readers' comments (5)
Pharma Giles | 23-Jul-2008 3:12 pm
Nice work
That's a good hire from GSK, getting closer to the regulator will make a big difference.
Unsuitable or offensive? Report this comment
Djimi Hill | 23-Jul-2008 3:14 pm
Slow coaches
Why did it take so long to find a replacement for Bondy? Surely general counsel at GSK is a job any self-respecting lawyer would want? Maybe there's more to it...
Unsuitable or offensive? Report this comment
Curious pharma lawyer | 23-Jul-2008 3:28 pm
Sidley Lost Him
This could be big blow to Sidley's life sciences and pharma practice. Troy did a lot of the liaison work between drug companies and the FDA - a stable flow of business in lean times. Anyone know what their plans are now?
Unsuitable or offensive? Report this comment
Gary Smith Kline | 23-Jul-2008 3:34 pm
Bad call
They should've hired a patent litigator. I though protecting their patents against generics was a bigger priority for GSK.
Unsuitable or offensive? Report this comment
Pharm hand | 23-Jul-2008 4:02 pm
Troy leaving Sidley
Re the last post, it might be a loss of talent for the firm but it's got to be useful for them having an alumnus inside GSK, surely? That's no bad client to have.
Unsuitable or offensive? Report this comment